267 related articles for article (PubMed ID: 36819348)
1. The Incidence of Long-Term Fatigue in Patients Who Achieved Remission From COVID-19 at King Abdulaziz Medical City.
Alotibi WM; Alzeer Z; Alfarhan IF; Alharbi AD; Alhaqbani FA; Almutairi AS; Alhazmi TM
Cureus; 2023 Jan; 15(1):e33869. PubMed ID: 36819348
[TBL] [Abstract][Full Text] [Related]
2. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
[TBL] [Abstract][Full Text] [Related]
3. Neurological Manifestations in Hospitalized Geriatric Patients With COVID-19 at King Abdulaziz Medical City in Jeddah, Western Region, Saudi Arabia From 2020 to 2021: A Cross-Sectional Study.
Marghalani YO; Kaneetah AH; Khan MA; Albakistani AA; Alzahrani SG; Kidwai A; Alansari KW; Alhamid HS; Alharbi MH; Attar A
Cureus; 2023 Sep; 15(9):e45759. PubMed ID: 37876390
[TBL] [Abstract][Full Text] [Related]
4. Persistent Symptoms Post-COVID-19: An Observational Study at King Abdulaziz Medical City, Jeddah, Saudi Arabia.
Jabali MA; Alsabban AS; Bahakeem LM; Zwawy MA; Bagasi AT; Bagasi HT; Aldosary TA
Cureus; 2022 Apr; 14(4):e24343. PubMed ID: 35607525
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Self-Management Among Healthcare Providers in King Abdulaziz Medical City, Riyadh: A Cross-Sectional Pilot Study.
Alhussein NA; Mahzari MM; Aljumaie NM; Alosaimi MI; Almansouf AS; Alkahtani FK
Cureus; 2021 Sep; 13(9):e18155. PubMed ID: 34703691
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Fatigue and Mental Illness Symptoms in Long COVID: Protocol for a Prospective Cohort Multicenter Observational Study.
Pires L; Reis C; Mesquita Facão AR; Moniri A; Marreiros A; Drummond M; Berger-Estilita J
JMIR Res Protoc; 2024 Jan; 13():e51820. PubMed ID: 38241071
[TBL] [Abstract][Full Text] [Related]
8. COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia.
Khodeir MM; Shabana HA; Rasheed Z; Alkhamiss AS; Khodeir M; Alkhowailed MS; Alharbi S; Alsoghair M; Alsagaby SA; Al Abdulmonem W
PLoS One; 2021; 16(12):e0260259. PubMed ID: 34879074
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
10. Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period.
Dagher H; Chaftari AM; Subbiah IM; Malek AE; Jiang Y; Lamie P; Granwehr B; John T; Yepez E; Borjan J; Reyes-Gibby C; Flores M; Khawaja F; Pande M; Ali N; Rojo R; Karp DD; Chaftari P; Hachem R; Raad II
Elife; 2023 Feb; 12():. PubMed ID: 36748905
[TBL] [Abstract][Full Text] [Related]
11. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
12. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
[TBL] [Abstract][Full Text] [Related]
13. Post-COVID-19 fatigue and health-related quality of life in Saudi Arabia: a population-based study.
Al-Johani MS; Khalil R; Al-Mohaimeed YA; Al-Mundarij OM; Al-Samani AS; Al-Saqry OS; Al-Saawi AA; Al-Dhali IK; Al-Essa WA
Front Public Health; 2023; 11():1254723. PubMed ID: 37869192
[TBL] [Abstract][Full Text] [Related]
14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
15. Physician's Perception Toward Using Telemedicine During COVID-19 Pandemic in King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Altulaihi BA; Alharbi KG; Alhassan AM; Altamimi AM; Al Akeel MA
Cureus; 2021 Jul; 13(7):e16107. PubMed ID: 34350074
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Outcome of Acute Kidney Injury in Patients Hospitalized With Coronavirus Disease-19 at a Tertiary Care Medical Center in Saudi Arabia.
Farooqui MA; Almegren A; Binrushud SR; Alnuwaiser FA; Almegren NM; Alhamied NA; Aloraifi EA; Alothman AM; Aldafas MA; Ardah HI; Alhejaili FF
Cureus; 2021 Oct; 13(10):e18927. PubMed ID: 34812311
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. Presentation and Outcomes of Patients With End-Stage Kidney Disease Hospitalized With COVID-19 at a Tertiary Center in Riyadh, Kingdom of Saudi Arabia.
Tawhari M; Alrushid E; Alquwaiee G; Alanazi S; Alkhudair J; Aldalaan A; Alsuwaid S; Alabdulkarim A; Tawhari F; Hattan KM; Tawhari I; Radwi M
Cureus; 2022 Mar; 14(3):e23575. PubMed ID: 35371886
[TBL] [Abstract][Full Text] [Related]
19. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis.
Premraj L; Kannapadi NV; Briggs J; Seal SM; Battaglini D; Fanning J; Suen J; Robba C; Fraser J; Cho SM
J Neurol Sci; 2022 Mar; 434():120162. PubMed ID: 35121209
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
